Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $113.3500 (-1.94%) ($113.0300 - $115.2000) on Wed. Aug. 10, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.14% (three month average) | RSI | 25 | Latest Price | $113.3500(-1.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -3.2% a day on average for past five trading days. | Weekly Trend | LGND declines -5.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.07% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) IPO(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.07% (StdDev 2.14%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
Resistance Level | $129.25 | 5 Day Moving Average | $120.42(-5.87%) | 10 Day Moving Average | $127.11(-10.83%) | 20 Day Moving Average | $129.25(-12.3%) | To recent high | -18.2% | To recent low | 1.4% | Market Cap | $1.822b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |